Cited by 276CRISPR and Genetic EngineeringRNA regulation and diseaseAnimal Genetics and Reproduction

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR–dCas9-activator transgenic mice

Zhou, Haibo, Liu, Junlai, Zhou, Changyang, Gao, Ni, Rao, Zhiping, Li, He, Hu, Xinde, Li, Changlin, Yao, Xuan, Shen, Xiaowen, Sun, Yidi, Wei, Yu, Liu, Fei, Ying, Wenqin, Zhang, Junming, Tang, Cheng, Zhang, Xu, Xu, Huatai, Shi, Linyu, Cheng, Leping, Huang, Pengyu, Yang, Hui·2018·Nature Neuroscience

DOI 10.1038/s41593-017-0060-6

Open this paper in CoChat — free account

Abstract

Despite rapid progresses in the genome-editing field, in vivo simultaneous overexpression of multiple genes remains challenging. We generated a transgenic mouse using an improved dCas9 system that enables simultaneous and precise in vivo transcriptional activation of multiple genes and long noncoding RNAs in the nervous system. As proof of concept, we were able to use targeted activation of endogenous neurogenic genes in these transgenic mice to directly and efficiently convert astrocytes into functional neurons in vivo. This system provides a flexible and rapid screening platform for studying complex gene networks and gain-of-function phenotypes in the mammalian brain.

Integrity signals

Registry

Crossref · 10.1038/s41593-017-0060-6

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
McCarthy, K. D., & de Vellis, J. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.85.3.890 · Cited by 3,825
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Expression of a single transfected cDNA converts fibroblasts to myoblasts
Davis, R. L., Weintraub, H. M., & Lassar, A. B. (1987) · Cell · doi:10.1016/0092-8674(87)90585-x · Cited by 3,388
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
Hilton, I. B., D’Ippolito, A. M., Vockley, C. M., Thakore, P. I., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3199 · Cited by 1,931
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,728
Self-citation

Show all 57 references

Sorted by citations

Items 201–276 of 276

Endosomal Escapable and Nuclear Localizing Cationic Polyaspartate-Based CRISPR Activation System for Preventing Respiratory Virus Infection by Specifically Inducing Interferon-λ
Liu, S., Deng, S., Li, M., Chen, J., Yuan, Y., Zhao, H., Zhou, J., Wang, J., Zhang, H., & Cheng, D. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c16588 · Cited by 5
Optimal tagging strategies for illuminating expression profiles of genes with different abundance in zebrafish
Liu, J., Li, W., Jin, X., Lin, F., Han, J., & Zhang, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-05686-1 · Cited by 6
Self-citation
Application of novel CRISPR tools in brain therapy
Shang, J., Song, F., Zhang, Z., Chen, D., & Yang, S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122855 · Cited by 5
The Promise of Epigenetic Editing for Treating Brain Disorders
González-Molina, L. A., Dolga, A. M., Rots, M. G., & Sarno, F. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_4 · Cited by 5
Efficient, cell-type-specific production of flavonols by multiplexed CRISPR activation of a suite of metabolic enzymes
Houbaert, A., Tendon, V. D., Hoermayer, L., Morffy, N., Strader, L. C., & Geldner, N. (2025) · Nature Communications · doi:10.1038/s41467-025-61742-w · Cited by 5
SERBP1-PCIF1 complex-controlled m6Am modification in glutamatergic neurons of the primary somatosensory cortex is required for neuropathic pain in mice
Huang, Y., Ma, G., Xie, S., Wei, R., Liu, Y., Zeng, Y., Zhao, Y., Wang, Q., Li, Y., Huang, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62565-5 · Cited by 5
Animal models built for women’s brain health: Progress and potential
Morrison, K. E. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100872 · Cited by 5
Biofabrication of synthetic human liver tissue with advanced programmable functions
Florentino, R. M., Morita, K., Haep, N., Motomura, T., Díaz‐Aragon, R., Faccioli, L. A. P., de l’Hortet, A. C., Cetin, Z., Frau, C., Vernetti, L. A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105503 · Cited by 5
In vivo screening identifies SPP2, a secreted factor that negatively regulates liver regeneration
Lin, Y.-H., Zeng, Q., Jia, Y., Wang, Z., Li, L., Hsieh, M.-H., Cheng, Q., Pagani, C. A., Livingston, N., Lee, J., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000402 · Cited by 5
Nuclear-Targeting Delivery of CRISPRa System for Upregulation ofβ-Defensin against Virus Infection by Dexamethasone and Phenylalanine Dual-Modified Dendrimer
Zuo, M., Li, M., Liu, S., Chen, B., & Cheng, D. (2020) · Advances in Polymer Technology · doi:10.1155/2020/6582825 · Cited by 5
Various strategies of effector accumulation to improve the efficiency of genome editing and derivative methodologies
Kunii, A., Yamamoto, T., & Sakuma, T. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00469-y · Cited by 5
Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineeringPreprint
Dong, M. B., Tang, K., Zhou, X., Shen, J., Chen, K., Kim, H. R., Zhou, J., Cao, H., Vandenbulcke, E., Zhang, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.14.532657 · Cited by 5
Efficient DNA- and virus-free engineering of cellular transcriptomic states using dCas9 ribonucleoprotein (dRNP) complexes
Schmidt, T., Wiesbeck, M. F., Egert, L., Truong, T.-T., Danese, A., Voshagen, L., Imhof, S., Borgia, M. I., Deeksha, Neuner, A. M., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf235 · Cited by 4
Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Rivera, F. V., Furino, V. D. O., & Sponton, C. H. (2023) · Journal of Visualized Experiments · doi:10.3791/64849 · Cited by 4
Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer
Marca, J. E. L., Diepstraten, S. T., Kelly, G. L., & Herold, M. J. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062624-104149 · Cited by 4
CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice
Geng, J., Wang, X., Pan, J., Khan, D., Pimcharoen, S., Zhang, Y., Mosammaparast, N., Hirose, S., Petrucelli, L., Brandman, O., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3551 · Cited by 4
Dead Cas Systems: Types, Principles, and Applications
Brezgin, S., Kostyusheva, A., Kostyushev, D. S., & Chulanov, V. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.14 · Cited by 5
65 YEARS OF THE DOUBLE HELIX: The advancements of gene editing and potential application to hereditary cancer
Tan, Z. Y., Huang, T., & Ngeow, J. Y. Y. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0039 · Cited by 5
Protocol to rapidly verify silent gene reporter in human pluripotent stem cells using CRISPR activation
Wu, Y., Zhong, A., Ramirez, B., Wai, S. S., & Zhou, T. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.104164 · Cited by 3
Tailoring Cardiac Synthetic Transcriptional Modulation Towards Precision Medicine
Schoger, E., Lelek, S., Panáková, D., & Zelarayan, L. C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.783072 · Cited by 3
Adding a Chemical Biology Twist to CRISPR Screening
Huang, S., & Baskin, J. M. (2022) · Israel Journal of Chemistry · doi:10.1002/ijch.202200056 · Cited by 3
Targeting epigenetic aberrations of sarcoma in CRISPR era
Tanaka, M., & Nakamura, T. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23142 · Cited by 2
Rosa26-LSL-dCas9-VPR: a versatile mouse model for tissue specific and simultaneous activation of multiple genes for drug discovery
Pakalniškytė, D., Schönberger, T., Strobel, B., Stierstorfer, B., Lamla, T., Schuler, M. J., & Lenter, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-23127-7 · Cited by 3
Transgenic mice for in vivo epigenome editing with CRISPR-based systemsPreprint
Gemberling, M. P., Siklenka, K., Rodriguez, E., Eisinger, K. R. T., Barrera, A., Liu, F., Kantor, A., Li, L., Cigliola, V., Hazlett, M. F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.08.434430 · Cited by 3
Self-citation
Cancer gene therapy: historical perspectives, current applications, and future directions
Zeng, J., Luo, J., & Zeng, Y. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01712-z · Cited by 3
Long noncoding RNA SALTe1, microvascular ageing, and cardiac dysfunction
Li, H., Xiao, X., Zhou, Y., Zhang, Y., Kang, J., Yuan, Z., He, J., Guerra, J. R. B., Lerchenmüller, C., Margulies, K. B., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag356 · Cited by 2
Self-citation
Gene therapy for pathologic gene expression
Montefiori, L. E., & Nóbrega, M. A. (2019) · Science · doi:10.1126/science.aaw0635 · Cited by 2
Editing the Epigenome in Neurodegenerative Diseases
Vetchinova, A. S., Fedotova, E. Y., & Illarioshkin, S. N. (2021) · Neurochemical Journal · doi:10.1134/s1819712421040152 · Cited by 2
A systematic screening assay identifies efficient small guide RNAs for CRISPR activation
Arvidsson, E., Lobo, D. D., Sabarese, E., Duarte, F. T., Nobre, R. J., Lundberg, C., & Quintino, L. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1336313 · Cited by 2
The transformational impact of site-specific DNA modifiers on biomedicine and agriculture
Polkoff, K. M., & Piedrahita, J. A. (2018) · Animal Reproduction · doi:10.21451/1984-3143-ar2018-0065 · Cited by 2
Enhancing Cardiomyocyte Transcription Using In Vivo CRISPR/Cas9 Systems
Schoger, E., & Zelarayan, L. C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2707-5_5 · Cited by 2
Novel Genetic Activation Screening in Liver Repopulation and Cancer: Now CRISPR Than Ever!
Preziosi, M., & Monga, S. P. (2018) · Hepatology · doi:10.1002/hep.30084 · Cited by 2
Comparative Analysis and Rational Design of dCas9-VP64 Variants for CRISPR ActivationPreprint
Omachi, K., & Miner, J. H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.13.456279 · Cited by 2
Applications of CRISPRi and CRISPRa in Drug Discovery
Gilbert, L. A. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch10 · Cited by 2
Acoustically Targeted Noninvasive Gene Therapy in Large Brain RegionsPreprint
Nouraein, S., Lee, S., Saenz, V. A., Mundo, H. C. D., Yiu, J., & Szablowski, J. O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.19.524626 · Cited by 2
3D organization of enhancers in MuSCs
He, L., Sun, H., & Wang, H. (2024) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2024.01.011 · Cited by 1
HDAC3 Epigenetic Suppression by Electroacupuncture Restores AMPA Receptor Function and Synaptic Plasticity in Alzheimer’s Disease Models
Li, H., Deng, B., Lin, M., Lai, L., Zhao, J., & Li, Y. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08892-8 · Cited by 2
Self-citation
Combinatorial protein engineering identifies potent CRISPR activators with reduced toxicity
Giddins, M. J., Kratz, A. F., Santos, M. B. D. L., Forget, A., Tiwari, R., Jang, G. Μ., Blazejewski, T., Qin, C., Huang, Y., Lao, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65986-4 · Cited by 2
CRISPR-Cas9—The Potential “Holy Grail” for Generating Biomedically Relevant Cells through Cell Fate Engineering
Krishnamoorthy, V., & Haigh, J. J. (2021) · Re GEN Open · doi:10.1089/regen.2021.0003 · Cited by 1
Therapeutic targeting non-coding RNAs
Ray, R. M., Lazăr, A. D., Balahura, L.-R., Dobranici, A., Costache, M., & Dinescu, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90406-3.00006-3 · Cited by 1
CRISPER-RNA Guided Gene Editing and Implications in Endogenous Genes Activation
Qamar, M., Tanvir, K., Akbar, S., Ghani, U., Ali, H., Bilal, M., Rehman, A., Arif, Z., & Batool, S. (2020) · Scholars International Journal of Biochemistry · doi:10.36348/sijb.2020.v03i03.006 · Cited by 1
Development and Application of CRISPR-Mediated Genetic Screening in Oncology
Li, W. (2020) · International Conference on Biomedical and Bioinformatics Engineering (ICBBE) · doi:10.1145/3444884.3444909 · Cited by 1
MicroRNAs Regulating Autophagy in Neurodegeneration
Lai, Q., Kovzel, N., Konovalov, R., & Vinnikov, I. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-2830-6_11 · Cited by 1
Epigenome Editing Enters the Arena. A New Tool to Reveal (and Reverse?) Pathologic Gene Regulation
Tan, Q., & Tschumperlin, D. J. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1239ed · Cited by 1
Genetic and Epigenetic Modulation of Gene Expression by CRISPR‐dCas Systems
Noordermeer, J. N., Chen, C., & Qi, L. S. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch12 · Cited by 1
CRISPR activation of Tfeb , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strengthPreprint
James, A., Hendrixson, J. A., Kadhim, I., Marques-Carvalho, A., Laster, J., Crawford, J., Thostenson, J., Sato, A. Y., Almeida, M., & Onal, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.26.615175 · Cited by 1
Bcl11b orchestrates subcerebral projection neuron axon development via cell-autonomous, non-cell-autonomous, and subcellular mechanismsPreprint
Itoh, Y., Woodworth, M. B., Greig, L. C., Engmann, A. K., Tillman, D. E., Hatch, J. J., & Macklis, J. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.20.619265 · Cited by 1
Bcl11b orchestrates subcerebral projection neuron axon development via cell-autonomous, non-cell-autonomous, and subcellular mechanismsPreprint
Itoh, Y., Woodworth, M. B., Greig, L. C., Engmann, A. K., Tillman, D. E., Hatch, J. J., & Macklis, J. D. (2025) · eLife · doi:10.7554/elife.105678.1 · Cited by 1
A novel, high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivoPreprint
Diepstraten, S. T., Deng, Y., Potts, M. A., Heidersbach, A. J., Koenig, C., Dorighi, K. M., Tai, L., Kueh, A. J., Whelan, L., Chang, C. W. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.22.666069 · Cited by 1
Enhancing the Efficiency of CRISPR/Cas9 Precise Gene Editing for Cystic Fibrosis Gene Therapy
Seigel, K. E. (2018) · TSpace (University of Toronto)
Oligonucleotide Targeting of Long Non-coding RNAs
Blokhin, I. O., Khorkova, O., Hsiao, J. H., & Wahlestedt, C. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00181
In Vivo Cell Conversion as a New Cell Therapy
Li, H., Zhang, L., Chen, Y., Wu, Z., Lei, Z., & Chen, G. (2019) · Current human cell research and applications · doi:10.1007/978-981-13-3672-0_10
Self-citation
〔504〕金属の摩耗に及ぼす温度の影響, 〔J.K.Lancaster, Phys.Soc., Proc., Sections B., 1957-1,Vol.20,Part 1,p.112〜118,図5〕
笹田直 (1958) · Nihon Kikai Gakkaishi/Journal of the Japan Society of Mechanical Engineers
Identification and analysis of genetic and chemical modulators of iron metabolism
Hawula, Z. J. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.225904 · Cited by 1
Utilizing CRISPR/Cas9 Technologies for in vivo Disease Modeling and Therapy
Badertscher, L., & Porritt, M. J. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch7
In vivo application of CRISPR/Cas9 mediated gene re-expression in the failing mouse and human myocardium
Schoger, E. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9564
CRISPR, epigenetics, and cancer
Martella, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91367-6.00007-6
In vivo screening of tumor-hepatocyte interactions identifies Plexin B2 as a gatekeeper of liver metastasisPreprint
Borrelli, C., Roberts, M., Eletto, D., Lafzi, A., Kretz, J. A., Fazilaty, H., Hussherr, M., Vinzoni, E. G., Handler, K., Michler, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.15.540681
Treating Alzheimer’s and ATTR using CRISPR-Cas9 to target amyloidosis
Joshi, P., Guilz, N. C., & Amendola, M. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.4806
High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogeneticsPreprint
Tang, K., Zhou, X., Fang, S., Vandenbulcke, E., Du, A., Shen, J., Cao, H., Zhou, J., Chen, K., Shan, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.14.585126
CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
Megagiannis, P., Rouleau, G. A., & Zhou, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00021-2
Genome Editing Technologies for Investigation of Activity-Dependent Transcription
Tuscher, J. J., Phillips, R. A., & Day, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-68550-7_16
Genome and Epigenome Engineering Approaches to Studying Neuronal Activity-Dependent Transcriptional Enhancers
Narayanan, A., & West, A. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-68550-7_7
Applications of CRISPR technology
Du, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23865-9.00003-4
Application and Prospect of Gene Editing Technology in Immunotherapy
Zhao, Y. (2025) · Highlights in Science Engineering and Technology · doi:10.54097/814b9h72
Bcl11b orchestrates subcerebral projection neuron axon development via cell-autonomous, non-cell-autonomous, and subcellular mechanismsPreprint
Itoh, Y., Woodworth, M. B., Greig, L. C., Engmann, A. K., Tillman, D. E., Hatch, J. J., & Macklis, J. D. (2025) · eLife · doi:10.7554/elife.105678
Dystrophin Restorative and Compensatory Gene Addition Therapies for Duchenne Muscular Dystrophy: Could CRISPRa Provide a Realistic Alternative?
Rostamitehrani, Z., Javed, R., & Popplewell, L. J. (2025) · Muscles · doi:10.3390/muscles4040052
Transgenic dCas9-DNMT3A mouse lines enable ex vivo and in vivo methylation editing with locus-dependent transcriptional effectsPreprint
Kalomoiri, M., Sorini, C., Vos, S. V. T., Camargo, A., Tsalikou, A., Krstic, A., Prakash, C. R., Svenningsson, P., Needhamsen, M., Kakhki, M. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.708277
CRISPR-mediated editing of cis-regulatory elements in early mouse embryos: a tool for studying pluripotency gene regulation
Driscoll, C. S., Kim, J., & Knott, J. G. (2026) · Reproduction · doi:10.1093/reprod/xaag042
Quantifying Haematopoietic Cell Dynamics
Hustin, L. (2022) · theses.fr (ABES) · doi:10.70675/48546646z0fa0z4e9bzb5a0zb1067f26721d
Advances and clinical potential of epigenome editing
Choi, I., Kim, S., & Baek, I. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06311-0
Trdn-as directs m6A-dependent transcriptional termination for accurate triadin isoform switching, preventing aberrant dyads and cardiomyopathy
Hofmann, T., Hettrich, S., Idrissou, B. M. G., Waechter, C., Weiss, M., Hachim, S., Kreher, S., Staps, M., Cañes, L., Pankuweit, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75985-8
Dual-mode application of transcriptional regulation and DNA editing using the ultra-compact TnpB system
Oh, Y., Jeon, S., Gwon, L. W., Sim, B., & Lee, S. H. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag849
A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo
Diepstraten, S. T., Deng, Y., Potts, M. A., Heidersbach, A. J., Koenig, C., Dorighi, K. M., Tai, L., Kueh, A. J., Whelan, L., Chang, C. W. T., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec0722 · Cited by 1
An Overview of Programmable Epigenetic Editing Based on CRISPR Tools for Gene Expression Regulation
Djordjevič, M., Dinić, S., Sarič, A., Uskoković, A. S., & Vidaković, M. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5547-4_5
An engineered, compact Cas12m variant for multiplexed gene activation in vivo
Zhang, H., Yang, L., Liu, Y., Han, D., Li, Y., Lin, J., Wang, B., Hu, J., Zhang, Y., Zhang, Y., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03352-5
Self-citation

Authors: Zhou, H., Liu, J., Zhou, C., Gao, N., Rao, Z., Li, H., Hu, X., Li, C., Yao, X., Shen, X., Sun, Y., Wei, Y., Liu, F., Ying, W., Zhang, J., Tang, C., Zhang, X., Xu, H., Shi, L., Cheng, L., Huang, P., & Yang, H.
Affiliations: Chinese Academy of Sciences (CN)
ShanghaiTech University (CN)
Corresponding author: Huang, Pengyu
Yang, Hui
ORCID: Zhou, Haibo
Zhou, Changyang
Li, He
Hu, Xinde
Li, Changlin
Yao, Xuan
Sun, Yidi
Liu, Fei
Ying, Wenqin
Zhang, Junming
Tang, Cheng
Zhang, Xu
Xu, Huatai
Shi, Linyu
Huang, Pengyu
Yang, Hui
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-01-15
Volume: 21
Issue: 3
Pages: 440-446
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/s41593-017-0060-6
OpenAlex: W2783322400
Cited by: 276
References: 57
Citations by year: 2026: 10 · 2025: 26 · 2024: 37 · 2023: 36 · 2022: 38 · 2021: 35 · 2020: 39 · 2019: 34 · 2018: 20
FWCI: 11.38
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
Keywords: CRISPR/dCas9, transcriptional activation, transgenic mice, long non-coding RNA, astrocyte-to-neuron conversion, neurogenesis, gene networks, brain
MeSH terms: Animals, Astrocytes, Brain Chemistry, DNA-Binding Proteins, Female, Male, Mice, Transgenic, Nerve Tissue Proteins, Nervous System, Neurons, Nuclear Proteins, Transcriptional Activation, Mice, Primary Cell Culture, RNA, Long Noncoding, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR–dCas9-activator transgenic mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks